Tcr2 Therapeutics Inc (TCRR)

$1.48 0.00 (0.00%)
16:00 EDT TCRR Stock Quote Delayed 30 Minutes

Why Is TCR2 Therapeutics (TCRR) Stock Up 30% Today?

By Dana Blankenhorn, InvestorPlace Contributor
A new deal offers a lifeline for TCRR stock and a compatible investment for Adaptimmune. Both companies are targeting solid cancer tumors.

CRISPR Layoffs 2023: Job Cuts Hit Gene-Editing Stocks FATE, TCRR, IPSC

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday

Select Price, Percent change, or Dollar change as the y-axis.
Select Area, Line, OHLC or Candlestick as the chart type.
Previous Close -
Market Cap 58.11M
PE Ratio -0.35
EPS -4.2
Volume (Avg. Vol.)
Day's Range -
52-Week Range $1.48 - $2.04
Dividend & Yield N/A (N/A)